Publications by authors named "Sant P Chawla"

63Publications

Aldoxorubicin in soft tissue sarcomas.

Future Oncol 2019 May 15;15(13):1429-1435. Epub 2019 Mar 15.

Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0922DOI Listing
May 2019

Exploiting Oncogenic Drivers along the Pathway for Cancer Therapy and Gene Therapy.

Mol Ther Oncolytics 2018 Dec 12;11:122-126. Epub 2018 Dec 12.

The Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA 90403, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23727705183003
Publisher Site
http://dx.doi.org/10.1016/j.omto.2018.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292824PMC
December 2018

Eribulin therapy for the treatment of patients with advanced soft tissue sarcoma.

Future Oncol 2018 Jul 7;14(16):1531-1545. Epub 2018 Feb 7.

Sarcoma Oncology Center, Santa Monica, CA 90403, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2017-0461
Publisher Site
http://dx.doi.org/10.2217/fon-2017-0461DOI Listing
July 2018

Rexin-G, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report.

Mol Clin Oncol 2017 Jun 28;6(6):861-865. Epub 2017 Apr 28.

Sarcoma Oncology Center/Cancer Center of Southern California, Santa Monica, CA 90403, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2017.1231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451875PMC
June 2017

Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives.

Adv Ther 2016 07 27;33(7):1055-71. Epub 2016 May 27.

Sarcoma Oncology Center/Cancer Center of Southern California, Santa Monica, CA, 90403, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-016-0344-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939148PMC
July 2016

Ewing Sarcoma in a Patient With Cowden Syndrome.

J Natl Compr Canc Netw 2015 Nov;13(11):1310-4

From the Department of Orthopaedic Surgery, David Geffen School of Medicine, UCLA, Los Angeles, California; Department of Orthopaedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Pathology, UCLA, Los Angeles, California; Department of Pathology, Khon Kaen University, Khon Kaen, Thailand; Sarcoma Oncology Center, Santa Monica, Santa Monica, California; and Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0161DOI Listing
November 2015

Giant-cell tumor of bone: treatment options and role of denosumab.

Biologics 2015 14;9:69-74. Epub 2015 Jul 14.

Sarcoma Oncology Center, Santa Monica, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BTT.S57359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507456PMC
July 2015

A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma.

Cancer 2015 Feb 13;121(4):570-9. Epub 2014 Oct 13.

Sarcoma Oncology Center, Santa Monica, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29081DOI Listing
February 2015

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.

J Clin Oncol 2014 Oct 2;32(29):3299-306. Epub 2014 Sep 2.

Sant P. Chawla, Sarcoma Oncology Center, Santa Monica; Andrew E. Hendifar, Cedars Sinai Medical Center, Los Angeles; Stew Kroll, Threshold Pharmaceuticals, South San Francisco; Kristen N. Ganjoo, Stanford University Medical Center, Stanford, CA; Lee D. Cranmer, University of Arizona Cancer Center, Tucson, AZ; Brian A. Van Tine and Douglas R. Adkins, Washington University in St Louis, St Louis, MO; Damon R. Reed, Moffitt Cancer Center and Research Institute, Tampa, FL; Scott H. Okuno, Mayo Clinic, Rochester, MN; and James E. Butrynski, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.3660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588714PMC
October 2014

Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.

J Surg Oncol 2015 Feb 30;111(2):152-7. Epub 2014 Aug 30.

Department of Orthopaedic Surgery, Los Angeles County - University of Southern California Medical Center, Keck School of Medicine, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.23775DOI Listing
February 2015

A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors.

Invest New Drugs 2014 Feb 1;32(1):171-7. Epub 2013 Nov 1.

University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-0037-6DOI Listing
February 2014

Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets.

Paediatr Drugs 2014 Feb;16(1):21-8

Department of Pediatrics, Hematology/Oncology, Mattel Children's Hospital at University of California, Los Angeles, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40272-013-0051-3DOI Listing
February 2014

Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.

Expert Rev Clin Pharmacol 2013 Sep 23;6(5):465-82. Epub 2013 Aug 23.

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2013.827397DOI Listing
September 2013

Treatment approaches to sarcoma in the community setting.

Authors:
Sant P Chawla

Clin Adv Hematol Oncol 2011 Jun;9(6):460-1

Santa Monica Oncology Center Santa Monica, CA, USA.

View Article

Download full-text PDF

Source
June 2011

Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene delivery.

Oncol Rep 2010 Oct;24(4):829-33

Oncology Research Unit, Epeius Biotechnologies Corporation, San Marino, CA 91108, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2010.829DOI Listing
October 2010

Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant.

Expert Opin Drug Metab Toxicol 2009 Dec;5(12):1607-14

The University of Texas Health Science Center, Institute for Drug Development at CTRC, Zeller's Building, San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425250903451675DOI Listing
December 2009

Review: desmoplastic small round cell tumor: current treatment approach and role of targeted therapy.

Clin Adv Hematol Oncol 2009 Jul;7(7):476-8

Institute for Drug Development, Cancer Therapy and Research Center, The University of Texas Health Science Center, San Antonio, TX 78229, USA.

View Article

Download full-text PDF

Source
July 2009

F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.

Clin Nucl Med 2008 Jan;33(1):8-13

PET Imaging Science Center, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e31815c4fd4DOI Listing
January 2008

Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases.

Ann Surg Oncol 2002 Mar;9(2):148-55

Division of Surgical Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02557366DOI Listing
March 2002